MedPath

Venclose, Inc.

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:3

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)β€’ Click on a phase to view related trials

Not Applicable
3 (100.0%)

Venclose RF Ablation System for the Treatment of IPVs

Not Applicable
Completed
Conditions
Chronic Venous Insufficiency
First Posted Date
2020-05-13
Last Posted Date
2022-05-27
Lead Sponsor
Venclose, Inc.
Target Recruit Count
27
Registration Number
NCT04386785
Locations
πŸ‡ΊπŸ‡Έ

Vein Center of East Texas at CardioStream, Tyler, Texas, United States

EU Post Market Clinical Follow-Up Study of the Venclose System for Saphenous Vein Incompetence

Not Applicable
Completed
Conditions
Chronic Venous Insufficiency
First Posted Date
2020-01-22
Last Posted Date
2022-04-04
Lead Sponsor
Venclose, Inc.
Target Recruit Count
25
Registration Number
NCT04236245
Locations
πŸ‡©πŸ‡ͺ

Venenzentrum am Bruehl, Leipzig, Germany

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.